바이오스펙트럼아시아

"Kangstem, Orgenesis ink deal to develop cell therapies for atopic dermatitis"

https://www.biospectrumasia.com/news/40/11804/kangstem-orgenesis-ink-deal-to-develop-cell-therapies-for-atopic-dermatitis.html

팜테크

"Kangstem Biotech Selects MaSTherCell as Contract Manufacturing Partner"

http://www.pharmtech.com/kangstem-biotech-selects-masthercell-contract-manufacturing-partner

마켓왓치

"Kangstem Biotech Selects Orgenesis' Subsidiary Masthercell for GMP Manufacturing of Furestem-AD� in Europe"

https://www.marketwatch.com/press-release/kangstem-biotech-selects-orgenesis-subsidiary-masthercell-for-gmp-manufacturing-of-furestem-ad-in-europe-2018-10-01